Skip to content
Technology
Ultratouch
Verify

Workflow-focused platform and complete prior authorization solution

Ultratouch
Engage

Enhance product access, automate patient outreach, and improve patient care

Ultratouch
Patient Management

Manage complicated patient-related accreditation requirements

ComplySuite

Built by pharmacists for pharmacy organizations, accreditation, licensing, and regulatory compliance management in one, configurable platform

Ready to Talk? Contact Us
agile solutions for every organization. Let's build yours.
events

Meet D2 Solutions at Trade & Channel Strategies | Cash Pharmacy Models

Cash pharmacy models are reshaping how products launch and how pharmacies grow. Connect with the D2 or join our Chief Growth Officer, David Suchanek, R.Ph., during his speaker session at Trade & Channel Strategies to talk through where a cash model fits your portfolio; from pricing and operations to the SP-lite, lifestyle, and the "tweener" patients it can reach.

350+ SPECIALTY PRODUCTS LAUNCHED & SUPPORTED  |   SUPPORTED 45%+ of U.S. SPECIALTY DRUG LAUNCHES IN 2025
Don't Miss David's Featured Speaking Session

Cash Pharmacy Models—Unlocking New Revenue Streams in a Changing Market

Speaker: David Suchanek, Chief Growth Officer, D2 Solutions
When: Tuesday, December 9, 2026 · 10:00 AM
Where:  Trade & Channel Strategies, W Hotel, Philadelphia, PA

With 25+ years in patient services, specialty pharmacy operations, access solutions, and GPO/channel management — including leadership roles at CuraScript (Express Scripts), Cardinal Health, and Caremark — D2 Solutions' Chief Growth Officer David Suchanek unpacks why cash models are growing so fast, what's changed to make cash pharmacies crucial to a product launch, and how to capture the SP-lite, lifestyle, and "tweener" populations becoming the market's untapped opportunity.

Who's attending Hub West?

Schedule time to meet with D2 leadership at Trade & Channel

Announcement

D2 Solutions has acquired ProModRx and their patient capture solution, dRx Request™

In April 2026, D2 acquired ProModRx and its patient capture solution, dRx Request™, extending D2's support across the full patient journey from prescription capture through benefit verification, prior authorization, dispensing, and engagement. Now part of D2’s UltraTouch® solutions, these capabilities target the exact barriers D2P models exist to solve: in recent D2 research, 21% of adults delayed starting a prescribed medication because of confusion or access issues.

Read More
patient receiving text on couch
More About D2 at Trade & Channel

FAQ

What key topics will be covered at Trade & Channel Strategies 2026? The 2026 program centers on the forces reshaping pharmacy and distribution models: traditional vs. innovative pharmacy models (including the rise of cash-pay), the direct-to-patient revolution, PBM reform and IRA impact, supply chain integrity and DSCSA serialization, global trade and tariffs, and health system partnerships. Content runs across multiple tracks — Pharmacy Models; Supply Chain, Distribution & Logistics; and Health Systems & Pharma Partnering — so attendees can tailor the agenda to their strategic priorities.
Who from D2 Solutions is attending Trade & Channel 2026? David Suchanek, R.Ph. (Chief Growth Officer) & Eirik Olsen (VP, Business Development) are attending Trade & Channel Strategies 2026 and are available for meetings December 8–10 at the W Hotel in Philadelphia.
Who from D2 Solutions is attending Hub West? David Suchanek (Chief Growth Officer) and Ray Rede (Managing Director, Manufacturer Services) are attending Hub and Specialty Pharmacy Models West 2026 and available for meetings on September 1–2, 2026.
What will David Suchanek's session on cash pharmacy models cover? Session Title: Cash Pharmacy Models—Unlocking New Revenue Streams in a Changing Market (Tuesday, December 9, 2026 · 10:00 AM)

The session explores why cash models are growing so rapidly, what has changed to make cash pharmacies crucial to a product launch, and why SP-lite, lifestyle, and "tweener" products are becoming the untapped market. David covers:
  • The essential operational components of successful cash pharmacy models — pricing frameworks and fair market value (FMV), technology platforms, workflow integration, and patient communication strategies
  • How cash pharmacy models diversify revenue streams and operational options, attract new patient populations, and create competitive differentiation in an increasingly complex reimbursement environment
  • The common pitfalls and barriers to success — from patient affordability concerns to payer relationships — and strategies to mitigate risk while maximizing the potential of cash-based dispensing
Where and when is Trade & Channel Strategies 2026? Trade & Channel Strategies 2026 takes place December 8–10, 2026 at the W Hotel in Philadelphia, PA.
What did D2's 2026 Patient Access Survey find? D2 Solutions' 2026 Patient Access Barriers survey of 1,000 U.S. adults (age 25+) put hard numbers behind a problem the industry has long felt: access and communication gaps are pushing patients off therapy before they ever start. 21% delayed starting a prescribed medication because of confusion or access issues, 11% never picked it up, 12% skipped doses, and 8% stopped early. Nearly half of prescriptions required prior authorization, 22% of patients said approval took longer than expected, and 47% described their most recent medication start with words like anxiety, confusion, or feeling "in limbo" — while only 20% called it "strong." As Dean Erhardt has put it, these aren't just paperwork hurdles; when communication breaks down, patients disengage before treatment begins. It's the case for direct-to-patient models built on speed, transparency, and proactive engagement. Connect with the team to get the full findings.